Medical News

RSS

BioMarin completes BMN 195 Phase 1 clinical trial for Duchenne muscular dystrophy

BioMarin Pharmaceutical Inc. announced today that it has completed the Phase 1 clinical study of BMN 195, a small molecule utrophin up-regulator, for the treatment of Duchenne muscular dystrophy (DMD). The Phase 1 clinical trial was a single-center, double-blind, placebo-controlled, single-dose escalation study followed by a multiple-dose escalation study in healthy volunteers.

3 Aug 2010

Allergan second-quarter diluted EPS increases to $0.78

Allergan, Inc. today announced operating results for the quarter ended June 30, 2010. Allergan also announced that its Board of Directors has declared a second quarter dividend of $0.05 per share, payable on September 7, 2010 to stockholders of record on August 17, 2010.

3 Aug 2010

Color red makes men more alluring to women: Study

It's a symbol of courage and sacrifice, of sin and sexuality, of power and passion - and now new research demonstrates that the color red makes men more alluring to women.In the United States, England, Germany and China, women found men more appealing when they were either pictured wearing red or framed in red, compared with other colors. The finding is reported in the August issue of the Journal of Experimental Psychology: General, published by the American Psychological Association.

3 Aug 2010

As e-prescribing becomes more popular, hurdles to adoption persist

The [Gary, IN] Post-Tribune: "While the trend toward e-prescribing has picked up steam in recent years, some doctors "said there continue to be barriers to widespread acceptance of a technology that could save thousands of lives.

3 Aug 2010

VertiFlex enrolls 150 patients in Superion Interspinous Spacer IDE clinical trial

VertiFlex, Inc., a leading innovator of minimally invasive and motion preserving spinal surgery technologies, today announced that 150 patients have been enrolled in its pivotal IDE clinical trial of the Superion Interspinous Spacer (ISS).

3 Aug 2010

Researchers develop techniques to identify evolution of drug resistance strains of malaria

Researchers at Case Western Reserve University developed techniques to quickly identify evolution of drug resistance in strains of malaria. Their goal is to enable the medical community to react quickly to inevitable resistance and thereby save lives while increasing the lifespan of drugs used against the disease.Currently, disease monitoring requires months of clinical trials. The new methods can provide more information in just days, and far cheaper.

3 Aug 2010

Patrys secures funding of up to A$15 million to support advancement of clinical products

Patrys Limited (ASX: PAB), a company focused on the development of natural human antibodies for the treatment of cancer, announced today that it has secured up to A$15 million in funding.

3 Aug 2010

Severe swine flu cases on the rise

Severe cases of swine flu requiring intensive care are on the rise this week. This has prompted a warning for the vulnerable to be vaccinated. NSW Health Communicable Diseases Branch director Dr Jeremy McAnulty said that the cases appear to be caused by the flu strain that caused the 2009 pandemic.

3 Aug 2010

Man dies at a routine traffic stop

In a bizarre incident a 58 year old man died after the police intercepted his car during a routine traffic inspection on Bermuda Street, Varsity Lakes, about 10am on Monday (AEST).

3 Aug 2010

High levels of lead found in Mount Isa children: Study

According to a report published in the Medical Journal of Australia (MJA) yesterday, on average one child in the Queensland mining town of Mount Isa will exceed safe lead levels every nine days. The report also claimed that not enough was done to address the problem. MP Betty Kiernan has defended the measures taken to address this serious problem.

3 Aug 2010

MBF announces sale of MSD to Water Street Healthcare Partners

MBF Healthcare Partners, L.P., a middle market healthcare focused private equity firm, announced it has sold Medical Specialties Distributors, LLC, to private equity firm Water Street Healthcare Partners.

2 Aug 2010

Pakistani officials fear cholera outbreak after massive flooding

After floods in northwest Pakistan have "already killed up to 1,200 people" and forced 2 million from their homes, authorities are now concerned about disease spread, the Associated Press reports.

2 Aug 2010

VHGI Holdings' Medical Office Software sold to a private company

VHGI Holdings, Inc. announced today that it has sold the assets of its medical practice management subsidiary, Medical Office Software, Inc., to a private company for a purchase price of between $1,200,000 - $1,300,000 and a warrant to purchase 1% of the common stock in the new company.

2 Aug 2010

Disparities in cardiovascular disease risk linked to socioeconomic differences between races: Study

A new UCLA study suggests that disparities in cardiovascular disease risk in the United States are due less to race or ethnicity than to socioeconomic status.

2 Aug 2010

Hospitals seek new ways to streamline care

News outlets report on hospital issues, including the differences between for-profit and nonprofit hospitals and efforts to streamline care.

2 Aug 2010

Tips for caregivers to better manage their loved one's health care

According to the National Alliance for Caregiving, more than 65 million people in the United States serve as informal caregivers, typically for family members. This equates to more than one out of every four people serving as unpaid caregivers.

2 Aug 2010

BIOTONE announces availability of Cocoa-Comfort Massage Balm

BIOTONE announces Cocoa-Comfort Massage Balm, one of the first balms for the professional massage therapy market. Created from a one-of-a-kind formulation whose leading ingredient Cocoa Butter is nature's ultimate hydrator, the new rich, thick balm gives a slight warming feel when applied at the same time it soothes and balances the skin to enhance its texture and tone.

2 Aug 2010

XACP invests $4M in $6.1M Series B financing for Health Market Science

Cross Atlantic Capital Partners announced today that it invested $4 million in a $6.1 million Series B financing for Health Market Science, a leading data and analytics provider for the healthcare industry. Cross Atlantic led the round with follow-on investments from other institutional investors, including Edison Venture Fund.

2 Aug 2010

Octapharma USA receives confirmation of orphan drug exclusivity from FDA for wilate

Octapharma USA has received confirmation of orphan drug exclusivity from the U.S. Food and Drug Administration for wilate (von Willebrand Factor/Factor VIII Concentrate, Human), the replacement therapy developed specifically for von Willebrand Disease. The approval comes from the FDA Office of Orphan Products Development, which helps to advance the development of products that demonstrate promise for the treatment of rare diseases.

2 Aug 2010

HemaCare second-quarter 2010 revenue increases 4%

HemaCare Corporation announced today profitable second quarter 2010 results with a 4% increase in revenue over the first quarter of the year, and $224,000 of net income, a significant improvement over the first quarter loss of $204,000. The first quarter loss included $184,000 in severance payments to the Company's former Chief Executive Officer and Chief Financial Officer.

2 Aug 2010